Glycolysis-Histone Lactylation Crosstalk Drives TXNIP-NLRP3-Mediated PANoptosome Assembly and PANoptosis Activation Underlying Diabetic Retinopathy Pathogenesis

Abstract

Diabetic retinopathy (DR), a major cause of vision loss in adults, involves aberrant metabolism and inflammation. This study investigated the interplay between glycolysis, histone lactylation, and PANoptosis in DR using human retinal pigment epithelial (RPE) cells under high glucose and diabetic mouse models. Results demonstrated a positive feedback loop where enhanced glycolysis increased histone lactylation, which in turn further promoted glycolysis. This cycle activated the expression of thioredoxin interacting protein (TXNIP) and NOD-like receptor thermal protein domain associated protein 3 (NLRP3), leading to PANoptosome formation and triggering PANoptosis, a coordinated cell death pathway contributing to DR pathology. Crucially, experiments manipulating TXNIP expression (via RNAi or overexpression) confirmed its central role in linking histone lactylation to NLRP3 activation and PANoptosome assembly. Importantly, inhibiting glycolysis or downregulating TXNIP successfully reduced histone lactylation, suppressed PANoptosome formation, and alleviated PANoptosis. These findings establish that the glycolysis-histone lactylation axis, mediated by TXNIP/NLRP3 signaling, drives PANoptosis in RPE cells through PANoptosome formation, playing a critical role in DR development. Targeting this specific pathway presents a promising new therapeutic strategy for diabetic retinopathy.

Keywords

diabetic retinopathy / glycolysis / histone lactylation / PANoptosis / thioredoxin interacting protein

References

[1] A. W. Stitt, T. M. Curtis, M. Chen, et al., “The Progress in Understanding and Treatment of Diabetic Retinopathy,” Progress in Retinal and Eye Research 51 (2016): 156-186.

[2] A. Rübsam, S. Parikh, P. E. Fort, “Role of Inflammation in Diabetic Retinopathy,” International Journal of Molecular Sciences 19, no. 4 (2018): 942.

[3] H. P. Hammes, “Diabetic Retinopathy: Hyperglycaemia, Oxidative Stress and Beyond,” Diabetologia 61, no. 1 (2018): 29-38.

[4] P. M. Martin, P. Roon, T. K. Van Ells, V. Ganapathy, S. B. Smith, “Death of Retinal Neurons in Streptozotocin-induced Diabetic Mice,” Investigative Ophthalmology & Visual Science 45, no. 9 (2004): 3330-3336.

[5] B. A. Coughlin, D. J. Feenstra, S. Mohr, “Müller Cells and Diabetic Retinopathy,” Vision Research 139 (2017): 93-100.

[6] S. Ghosh, H. Liu, M. Yazdankhah, et al., “βA1-Crystallin Regulates Glucose Metabolism and Mitochondrial Function in Mouse Retinal Astrocytes by Modulating PTP1B Activity,” Communications Biology 4, no. 1 (2021): 248.

[7] A. Lakkaraju, A. Umapathy, L. X. Tan, et al., “The Cell Biology of the Retinal Pigment Epithelium,” Progress in Retinal and Eye Research (2020): 100846.

[8] D. Tonade, T. S. Kern, “Photoreceptor Cells and RPE Contribute to the Development of Diabetic Retinopathy,” Progress in Retinal and Eye Research 83 (2021): 100919.

[9] M. J. Tarchick, A. H. Cutler, T. D. Trobenter, et al., “Endogenous Insulin Signaling in the RPE Contributes to the Maintenance of Rod Photoreceptor Function in Diabetes,” Experimental Eye Research 180 (2019): 63-74.

[10] C. Shi, P. Cao, Y. Wang, et al., “PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis,” Journal of Inflammation Research 16 (2023): 1523-1532.

[11] B. Briard, R. K. S. Malireddi, T. D. Kanneganti, “Role of Inflammasomes/Pyroptosis and PANoptosis During Fungal Infection,” PloS Pathogens 17, no. 3 (2021): e1009358.

[12] B. Banoth, S. Tuladhar, R. Karki, et al., “ZBP1 Promotes Fungi-Induced Inflammasome Activation and Pyroptosis, Apoptosis, and Necroptosis (PANoptosis),” Journal of Biological Chemistry 295, no. 52 (2020): 18276-18283.

[13] D. E. Place, S. Lee, T. D. Kanneganti, “PANoptosis in Microbial Infection,” Current Opinion in Microbiology 59 (2021): 42-49.

[14] Y. Rajesh, T. D. Kanneganti, “Innate Immune Cell Death in Neuroinflammation and Alzheimer's Disease,” Cells 11, no. 12 (2022): 1885.

[15] S. Christgen, R. E. Tweedell, T. D. Kanneganti, “Programming Inflammatory Cell Death for Therapy,” Pharmacology & Therapeutics 232 (2022): 108010.

[16] J. S. Park, C. J. Burckhardt, R. Lazcano, et al., “Mechanical Regulation of Glycolysis via Cytoskeleton Architecture,” Nature 578, no. 7796 (2020): 621-626.

[17] S. W. S. Leung, Y. Shi, “The Glycolytic Process in Endothelial Cells and Its Implications,” Acta Pharmacologica Sinica 43, no. 2 (2022): 251-259.

[18] D. Zhang, Z. Tang, H. Huang, et al., “Metabolic Regulation of Gene Expression by Histone Lactylation,” Nature 574, no. 7779 (2019): 575-580.

[19] J. Xiong, J. He, J. Zhu, et al., “Lactylation-Driven METTL3-Mediated RNA M(6)A Modification Promotes Immunosuppression of Tumor-Infiltrating Myeloid Cells,” Molecular Cell 82, no. 9 (2022): 1660-1677.e10.

[20] J. Yu, P. Chai, M. Xie, et al., “Histone Lactylation Drives Oncogenesis by Facilitating M(6)A Reader Protein YTHDF2 Expression in Ocular Melanoma,” Genome Biology 22, no. 1 (2021): 85.

[21] Z. Yang, C. Yan, J. Ma, et al., “Lactylome Analysis Suggests Lactylation-Dependent Mechanisms of Metabolic Adaptation in Hepatocellular Carcinoma,” Nature Metabolism 5, no. 1 (2023): 61-79.

[22] J. M. Tarr, K. Kaul, M. Chopra, E. M. Kohner, R. Chibber, “Pathophysiology of Diabetic Retinopathy,” ISRN Ophthalmology 2013 (2013): 343560.

[23] G. Li, A. A. Veenstra, R. R. Talahalli, et al., “Marrow-Derived Cells Regulate the Development of Early Diabetic Retinopathy and Tactile Allodynia in Mice,” Diabetes 61, no. 12 (2012): 3294-3303.

[24] B. A. Berkowitz, M. Gradianu, D. Bissig, T. S. Kern, R. Roberts, “Retinal Ion Regulation in a Mouse Model of Diabetic Retinopathy: Natural History and the Effect of Cu/Zn Superoxide Dismutase Overexpression,” Investigative Ophthalmology & Visual Science 50, no. 5 (2009): 2351-2358.

[25] S. Zafar, M. Sachdeva, B. J. Frankfort, R. Channa, “Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies,” Current Diabetes Reports 19, no. 4 (2019): 17.

[26] H. Kolb, E. Fernandez, B. Jones, and Nelson R, eds. Webvision: The Organization of the Retina and Visual System (University of Utah Health Sciences Center, 1995).

[27] J. Song, T. Liu, Y. Yin, et al., “The Deubiquitinase OTUD1 Enhances Iron Transport and Potentiates Host Antitumor Immunity,” Embo Reports 22, no. 2 (2021): e51162.

[28] W. F. Xu, Q. Zhang, C. J. Ding, et al., “Gasdermin E-Derived Caspase-3 Inhibitors Effectively Protect Mice From Acute Hepatic Failure,” Acta Pharmacologica Sinica 42, no. 1 (2021): 68-76.

[29] T. Müller, C. Dewitz, J. Schmitz, et al., “Necroptosis and Ferroptosis Are Alternative Cell Death Pathways That Operate in Acute Kidney Failure,” Cellular and Molecular Life Sciences 74, no. 19 (2017): 3631-3645.

[30] Q. Tian, B. Qin, Y. Gu, et al., “ROS-Mediated Necroptosis Is Involved in Iron Overload-Induced Osteoblastic Cell Death,” Oxidative Medicine and Cellular Longevity 2020 (2020): 1295382.

[31] S. Oh, J. Lee, J. Oh, et al., “Integrated NLRP3, AIM2, NLRC4, Pyrin Inflammasome Activation and Assembly Drive PANoptosis,” Cellular and Molecular Immunology 20, no. 12 (2023): 1513-1526.

[32] Y. Han, X. Xu, C. Tang, et al., “Reactive Oxygen Species Promote Tubular Injury in Diabetic Nephropathy: The Role of the Mitochondrial Ros-txnip-nlrp3 Biological Axis,” Redox Biology 16 (2018): 32-46.

[33] Z. Luo, M. Tian, G. Yang, et al., “Hypoxia Signaling in Human Health and Diseases: Implications and Prospects for Therapeutics,” Signal Transduction and Targeted Therapy 7, no. 1 (2022): 218.

[34] S. J. Kierans, C. T. Taylor, “Regulation of Glycolysis by the Hypoxia-Inducible Factor (HIF): Implications for Cellular Physiology,” The Journal of Physiology 599, no. 1 (2021): 23-37.

[35] Y. Huang, B. Mouttet, H. J. Warnatz, et al., “The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability,” Cancer Cell 36, no. 6 (2019): 630-644.e9.

[36] J. E. Fish, M. Cantu Gutierrez, L. T. Dang, et al., “Dynamic Regulation of VEGF-Inducible Genes by an ERK/ERG/p300 Transcriptional Network,” Development 144, no. 13 (2017): 2428-2444.

[37] R. Coppari, “Diabetes Present and Future,” International Journal of Biochemistry & Cell Biology 88 (2017): 197.

[38] E. Standl, K. Khunti, T. B. Hansen, O. Schnell, “The Global Epidemics of Diabetes in the 21st Century: Current Situation and Perspectives,” supplement, European Journal of Preventive Cardiology 26, no. 2 (2019): 7-14.

[39] M. YimamAhmed, S. Hambisa Ejigu, A. Zewudie Zeleke, M. Yimam Hassen, “Glycemic Control, Diabetes Complications and Their Determinants Among Ambulatory Diabetes Mellitus Patients in Southwest Ethiopia: A Prospective Cross-Sectional Study,” Diabetes, Metabolic Syndrome and Obesity 13 (2020): 1089-1095.

[40] L. Tang, G. T. Xu, J. F. Zhang, “Inflammation in Diabetic Retinopathy: Possible Roles in Pathogenesis and Potential Implications for Therapy,” Neural Regeneration Research 18, no. 5 (2023): 976-982.

[41] Z. Zeng, M. You, C. Fan, R. Rong, H. Li, X. Xia, “Pathologically High Intraocular Pressure Induces Mitochondrial Dysfunction Through Drp1 and Leads to Retinal Ganglion Cell PANoptosis in Glaucoma,” Redox Biology 62 (2023): 102687.

[42] J. M. Lopes de Faria, D. A. Duarte, C. Montemurro, A. Papadimitriou, S. R. Consonni, J. B. Lopes de Faria, “Defective Autophagy in Diabetic Retinopathy,” Investigative Ophthalmology & Visual Science 57, no. 10 (2016): 4356-4366.

[43] X. Xi, Y. Yang, J. Ma, et al., “MiR-130a Alleviated High-Glucose Induced Retinal Pigment Epithelium (RPE) Death by Modulating TNF-α/SOD1/ROS Cascade Mediated Pyroptosis,” Biomedicine & Pharmacotherapy 125 (2020): 109924.

[44] D. Ye, Y. Xu, Y. Shi, et al., “Anti-PANoptosis Is Involved in Neuroprotective Effects of Melatonin in Acute Ocular Hypertension Model,” Journal of Pineal Research 73, no. 4 (2022): e12828.

[45] A. N. Chen, Y. Luo, Y. H. Yang, et al., “Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects,” Frontiers in Immunology 12 (2021): 688910.

[46] E. E. Swinstead, V. Paakinaho, D. M. Presman, G. L. Hager, “Pioneer Factors and ATP-dependent Chromatin Remodeling Factors Interact Dynamically: A New Perspective: Multiple Transcription Factors Can Effect Chromatin Pioneer Functions Through Dynamic Interactions With ATP-dependent Chromatin Remodeling Factors,” BioEssays 38, no. 11 (2016): 1150-1157.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.